Telemedicine-Based Virtual Reality Clinic for the Treatment of Phobias

Arachnophobia Clinical Trial

Official title: Doxy.me VR vs. Telemental Health-Based Exposure Therapy

Status Recruiting

Clinical Trial Summary

The purpose of this study is to assess the feasibility of conducting a randomized controlled efficacy trial comparing the delivery of exposure therapy via a telemedicine-based virtual reality clinic (Doxy.me VR) vs. standard telemental health (TMH) to adults with intense fear of dogs, snakes, and/or spiders. The secondary purpose is to preliminarily examine the efficacy of using Doxy.me VR vs. TMH in reducing phobia severity.

Clinical Trial Description

This study aims to assess the feasibility of conducting a randomized controlled efficacy trial comparing the delivery of exposure therapy via a telemedicine-based virtual reality clinic (Doxy.me VR) vs. standard telemental health (TMH) to adults with intense fear of dogs, snakes, and/or spiders. This study will use feasibility randomized controlled efficacy trial design. This single-site trial will include up to 60 adults with self-reported fear of dogs, snakes, and/or spiders who will be randomly assigned via the REDCap Randomization Module using a 1:1 allocation ratio to receive 12 sessions of exposure therapy over the course of 3 months via standard telemental health (TMH; n=15) vs. Doxy.me VR (n=15), a telemedicine-based virtual reality clinic. ;

Related Conditions & MeSH terms

• Arachnophobia

• NCT number: NCT06302868
• Study type: Interventional
• Source: University of South Florida
• Contact: Kaitlyn R Schuler, PhD
• Phone: 813-396-9169
• Email: krschuler@usf.edu
• Status: Recruiting
• Phase: N/A
• Start date: October 3, 2023
• Completion date: August 1, 2024